These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 2788388)

  • 21. Defective calcium response in B-chronic lymphocytic leukemia cells. Alteration of early protein tyrosine phosphorylation and of the mechanism responsible for cell calcium influx.
    Michel F; Merle-Béral H; Legac E; Michel A; Debré P; Bismuth G
    J Immunol; 1993 Apr; 150(8 Pt 1):3624-33. PubMed ID: 8096854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal expression of interleukin-2 receptor (Tac antigen) in adult T-cell leukemia.
    Uchiyama T; Wano Y; Tsudo M; Umadome H; Hori T; Tamori S; Uchino H; Yodoi J; Maeda M; Kobayashi N
    Princess Takamatsu Symp; 1984; 15():253-8. PubMed ID: 6100643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-13 has only a subset of IL-4-like activities on B chronic lymphocytic leukaemia cells.
    Fluckiger AC; Brière F; Zurawski G; Bridon JM; Banchereau J
    Immunology; 1994 Nov; 83(3):397-403. PubMed ID: 7530690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
    Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
    Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Study of interleukins and their soluble receptors in B-cell chronic lymphatic leukemia].
    Parfieńczyk A; Kiersnowska-Rogowska B; Rogowski F
    Pol Merkur Lekarski; 2004 Jan; 16(91):22-5. PubMed ID: 15074015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyamine metabolism in chronic lymphocytic leukemia.
    Canellakis ZN; Portlock CA; Bondy PK
    Biochem Int; 1989 Apr; 18(4):741-9. PubMed ID: 2764974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytotoxic effect of hemin and protoporphyrin on chronic lymphocytic leukemia lymphocytes.
    Malik Z; Djaldetti M
    Exp Hematol; 1980 Aug; 8(7):867-79. PubMed ID: 16398018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normal and leukemic lymphocyte membrane fluidity and response to stimulation with ConA and PHA.
    Yang YZ; Hao TL; Qian M; Dai WX; Huangfu YM; Zhang ZH
    J Tongji Med Univ; 1989; 9(3):143-7. PubMed ID: 2600982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The P2X7 receptor of CLL lymphocytes-a molecule with a split personality.
    Di Virgilio F; Wiley JS
    Lancet; 2002 Dec; 360(9349):1898-9. PubMed ID: 12493250
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of a new fluorescent viscosity indicator to study the relationship between transmembrane potential and membrane dynamics of lymphocytes.
    Lakos Z; Volovyk ZM; Somogyi B; Demchenko OP; Damjanovich S
    Ukr Biokhim Zh (1978); 1990; 62(2):107-10. PubMed ID: 2368181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid and protein components of the syncytiotrophoblast plasma membrane inhibit lymphocyte proliferation by two distinct pathways.
    Lalmanach-Girard AC; Thibault G; Lacord M; Degenne D; Bardos P
    Immunol Lett; 1992 Apr; 32(2):131-8. PubMed ID: 1612636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Energy transfer efficiency on lymphocytes of leukemia patients measured by fluorescence polarization.
    Cohen-Kashi M; Haran M; Afrimzon E; Deutsch M
    Leuk Lymphoma; 2005 Jan; 46(1):113-20. PubMed ID: 15621788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol content and fluidity of normal human and chronic lymphocytic leukaemia lymphocytes in relation to serum cholesterol level.
    Peel WE; Thomson AE
    Leuk Res; 1980; 4(6):601-10. PubMed ID: 7206777
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of Ibrutinib on biophysical parameters of platelet in patients with chronic lymphocytic leukaemia.
    Popov VM; Matei CO; Omer M; Onisai M; Matei MB; Savopol T; Bumbea H; Moisescu MG
    Am J Blood Res; 2020; 10(6):311-319. PubMed ID: 33489439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new approach to comparing anti-CD20 antibodies: importance of the lipid rafts in their lytic efficiency.
    Hammadi M; Pers JO; Berthou C; Youinou P; Bordron A
    Onco Targets Ther; 2010 Jun; 3():99-109. PubMed ID: 20616960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of dynamic lipid changes after binding of interleukin 2 in chronic lymphatic leukemia lymphocytes indicates defective transmembrane signalling.
    Daefler S; Krueger GR
    Anticancer Res; 1989; 9(3):743-8. PubMed ID: 2788388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesterol modulation of membrane fluidity and ecto-nucleotide triphosphatase activity in human normal and CLL lymphocytes.
    Deliconstantinos G; Daefler S; Krueger GR
    Anticancer Res; 1987; 7(3 Pt B):347-52. PubMed ID: 2957950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of proliferation and differentiation antigens in response to modulation of membrane fluidity in chronic lymphocytic leukemia lymphocytes.
    Daefler S; Krueger GR
    Anticancer Res; 1989; 9(2):501-6. PubMed ID: 2751273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
    Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
    Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluidity of membrane lipids and lateral mobility of concanavalin A receptors in the cell surface of normal lymphocytes and lymphocytes from patients with malignant lymphomas and leukemias.
    Ben-Bassat H; Polliak A; Rosenbaum SM; Naparstek E; Shouval D; Inbar M
    Cancer Res; 1977 May; 37(5):1307-12. PubMed ID: 856460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.